Abstract
INTRODUCTION:The essential tremor is the most common tremor. It has not been described the association between diabetes and essential tremor. The objective of this case-control study is to document the association between diabetes mellitus and essential tremor.
METHODS:It was carried out a case-control study in incident patients of clinical population with essential tremor, paired by age and gender, who they were interrogated the antecedent of diabetes mellitus. The OR was determined by means of conditioned logistical regression.
RESULTS:262 cases of essential tremor and 262 controls were studied. The antecedent of diabetes mellitus was in 39 cases with essential tremor and in 24 controls, with an OR 2.15 (95 %% CI 1.05 to 4.41).
DISCUSSION:This case-control study in a clinical population shows that the patients with essential tremor have 2 times more probability of having the antecedent of diabetes mellitus.
References
Romero JP, Benito-León J, Bermejo-Pareja F. The NEDICES study: recent advances in the understanding of the epidemiology of essential tremor. Tremor Other Hyperkinet Mov 2012;2: Disponible en: http://tremorjournal.org/article/view/70.
Zesiewicz TA, Elble R, Louis ED, Hauser RA, Sullivan KL, Dewey RB, Ondo WG, et al. Practice parameter: therapies for essential tremor report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2005;64:2008-20.
Frishman WH, Saunders E. ?-Adrenergic blockers. J Clin Hypertens (Greenwich). 2011;13(9):649-53.
Li J, Cesari M, Liu F, Dong ?, Vellas ?. Effects of diabetes mellitus on cognitive decline in patients with Alzheimer disease: a systematic review. Can J Diabetes. 2017;41(1):114-9.
Deuschl G, Bain P, Brin M; Ad Hoc Scientific Committee. Consensus statement of the movement disorder society on tremor. Mov Disord. 1998; 13(Supl. 3):2-23.
Keogh RH, Cox DR. Introduction to case-control studies. En Keogh RH, Cox DR, editors. Case-control studies. Cambridge University Press; 2014. p. 8-30.
Pourhoseingholi MA, Baghestani AR, Vahedi M. How to control confounding effects by statistical analysis. Gastroenterol Hepatol Bed Bench. 2012;5(2):79-83.
Deng H, Le W, Jankovic J. Genetics of essential tremor. Brain 2007; 130:1456-64.
Louis ED. Environmental epidemiology of essential tremor. Neuroepidemiology. 2008;31:139-49.
Lucchini RG, Hashim D. Tremor secondary to neurotoxic exposure: mercury, lead, solvents, pesticides. En Lotti M, BNleecker MI, editores. Handbook of clinical neurology, vol. 131 (3rd series). Occupational Neurology. Elsevier BV; 2015. p. 241-9.
Louis ED, Zheng W, Jurewicz EC, Watner D, Chen J, Factor-Litvak P, Parides M. Elevation of blood ?-carboline alkaloids in essential tremor. Neurology 2002;59:1940-4.
Louis ED, Zheng W, Applegate L, Shi L, Factor-Litvak P. Blood harmane concentrations and dietary protein consumption in essential tremor. Neurology. 2005;65:391-6.
Louis ED, Jurewicz EC, Applegate L, Factor-Litvak P, Parides M, Andrews L, Slavkovich V, Graziano JH, Carroll S, Todd A. Association between essential tremor and blood lead concentration. Environ Health Perspect. 2003;111:1707-11.
Dogu O, Louis ED, Tamer L, Unal O, Yilmaz A, Kaleagasi H. Elevated blood lead concentrations in essential tremor: a case-control study in Mersin, Turkey. Environ Health Perspect. 2007;115:1564-8.
Louis ED, Factor-Litvak P, Parides M, Andrews L, Santella RM, Wolff MS. Organochlorine pesticide exposure in essential tremor: a case-control study using biological and occupational exposure assessments. Neurotoxicology. 2006;27:579-86.
Jiménez-Jiménez FJ, de Toledo-Heras M, Alonso-Navarro H, Ayuso-Peralta L, Arévalo-Serrano J, Ballesteros-Barranco A, Puertas I, Jabbour-Wadih T, Barcenilla ?. Environmental risk factors for essential tremor. Eur Neurol. 2007;58:106-13.
Keezer MR, Wolfson C, Postuma RB. Age, gender, comorbidity, and the MDS-UPDRS: results from a population-based study. Neuroepidemiology. 2016;46(3):222-7.
Louis ED. Essential tremors. A family of neurodegenerative disorders? Arch Neurol. 2009;66(10):1202-8.
LaRoia H, Louis ED. Association between essential tremor and other neurodegenerative diseases: what is the epidemiological evidence? Neuroepidemiology. 2011;37:1-10.
Mittal K, Katare DP. Shared links between type 2 diabetes mellitus and Alzheimer's disease: a review. Diabetes Metab Syndr. 2016;10(2 Supl. 1):S144-9.
Yang Y-W, Hsieh T-F, Li C-I, Liu C-S, Lin W-Y, Chiang J-H, Li T-C, et al. Increased risk of Parkinson disease with diabetes mellitus in a population-based study. Medicine (Baltimore). 2017;96(3):e5921.
Yue X, Li H, Yan H, Zhang P, Chang L, Li T. Risk of Parkinson disease in diabetes mellitus: an updated meta-analysis of population-based cohort studies. Medicine (Baltimore). 2016;95(18):e3549.
Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín ?, Agúndez JAG. The relationship between Parkinson's disease and essential tremor: review of clinical, epidemiologic, genetic, neuroimaging and neuropathological data, and data on the presence of cardinal signs of parkinsonism in essential tremor. Tremor Other Hyperkinet Mov 2012;2. Disponible en: http://tremorjournal.org/article/view/75.
McClean PL, Gault VA, Harriott P, Hõlscher C. Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: A link between diabetes and Alzheimer's disease. Eur J Pharmacol. 2010;630(1-3):158-62.
Duffy AM, Hõlscher C. The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease. Neuroscience. 2013;228:294-300.
Abboud H, Ahmed A, Fernandez HH. Essential tremor: Choosing the right management plan for your patient. Cleve Clin J Med. 2011;78(12):821-8.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.